Updated track record demonstrates significantly increased success rate for drug candidates validated by Attana
Just over a year ago, a retroactive study was published on Attana´s track record in drug development in IBI (International Biopharmaceutical Industry), read the full article her e. Today, updated results were published and the number of analyzed candidates for Attana in the preclinical phase amounts to 103 compared to 77 just over a year ago. The validated candidates have come further in the development process today, and the success rate is still significantly higher